BAC
41
-6
XRAY
31
-3
PCG
80
3
MAS
67
-3
CF
57
-3
AEE
61
3
NKE
46
12
MAT
51
-3
TDC
59
10
MOS
19
-4
LMT
47
7
VZ
47
2
MSI
72
2
GPC
37
-14
ROK
44
-7
INTU
63
-2
RRC
56
4
TRIP
66
5
WBA
24
-3
IFF
56
-3
BAC
41
-6
XRAY
31
-3
PCG
80
3
MAS
67
-3
CF
57
-3
AEE
61
3
NKE
46
12
MAT
51
-3
TDC
59
10
MOS
19
-4
LMT
47
7
VZ
47
2
MSI
72
2
GPC
37
-14
ROK
44
-7
INTU
63
-2
RRC
56
4
TRIP
66
5
WBA
24
-3
IFF
56
-3
Financhill
Back

ReGen III Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
28

GIII.V
ReGen III

Last Price:
0.21
Seasonality Move:
-3.13%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
28
ReGen III (GIII.V) is a Sell

Is ReGen III a Buy, Sell or Hold?

  • The current ReGen III [GIII.V] share price is $0.21. The Score for GIII.V is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • GIII.V is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

GIII.V Stock Price Chart

What is ReGen III's stock price today?

  • The ReGen III share price today is $0.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GIII.V is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

GIII.V Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 43.64 Sell
Chaikin Money Flow: 37250 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.21 - 0.23) Sell
Bollinger Bands (100): (0.23 - 0.31) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

GIII.V Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.22 Sell
20-day SMA: 0.22 Sell
50-day SMA: 0.24 Sell
200-day SMA: 0.31 Sell
8-day EMA: 0.22 Sell
20-day EMA: 0.22 Sell
50-day EMA: 0.24 Sell
200-day EMA: 0.31 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

ReGen III Earnings Growth & GIII.V Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

ReGen III Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):